Hälsa & åldrande

A Swedish study tracking 10,500 people over 60 years found that children who scored higher on reasoning tests at age 13 had significantly lower dementia risk in old age—independent of heart disease and diabetes. The finding suggests cognitive screening in childhood could identify high-risk individuals for early intervention, with implications for public health planning and long-term care resource allocation.EN

Researchers piloted a clinical decision support system designed to help primary care doctors safely manage patients taking multiple drugs—a growing challenge as populations age. The feasibility study suggests such tools could reduce dangerous drug interactions and improve care coordination, potentially lowering costs for health systems managing complex patients.EN

A researcher defends the long-term economic value of Finland's FINGER dementia prevention program against recent criticism. The debate matters because it will shape how healthcare systems and insurers decide whether to fund large-scale cognitive decline prevention efforts aimed at aging populations.EN

An international declaration now formally recognizes nutritional care as a fundamental human right, establishing a framework that could reshape healthcare policy and hospital standards worldwide. The move signals growing consensus that malnutrition—affecting millions globally—demands systemic change comparable to other recognized health entitlements.EN

Researchers found that fat infiltration in muscles is a critical but overlooked marker of muscle decline in chronic kidney disease patients. The discovery could reshape how doctors screen for and treat muscle wasting in this population, potentially improving outcomes and reducing healthcare costs associated with mobility loss and hospitalization.EN

A major clinical review finds that older adults with chronic kidney disease are at serious risk of malnutrition, despite commonly prescribed low-protein diets. The finding, endorsed by European kidney and nutrition societies, suggests healthcare systems need to rethink nutrition strategies for this vulnerable population to prevent costly complications.EN

A new reply in Environment International challenges how scientists measure Parkinson's disease mortality, potentially affecting how researchers link environmental exposures to this neurodegenerative disease. The clarification matters because inconsistent definitions could skew public health data and derail efforts to identify toxic triggers.EN

Researchers have advanced the definition and diagnosis of sarcopenia—age-related muscle loss—signaling progress in identifying a condition affecting millions of older adults. The clarity matters to healthcare systems, insurers, and senior care providers wrestling with how to screen for, treat, and manage this costly driver of disability and falls.EN

A new analysis of sarcopenia research reveals significant inconsistencies in how studies define and measure age-related muscle deterioration, hampering efforts to develop treatments and predict patient outcomes. The findings suggest the field needs standardized assessment methods to translate research into clinical and commercial solutions.EN

A major review found that the Clinical Frailty Scale reliably identifies elderly patients at highest risk of poor outcomes in hospitals. For healthcare systems and insurers, this tool could enable earlier intervention and better resource allocation—potentially reducing costly emergency readmissions and improving quality of care.EN

A systematic review has identified diagnostic criteria for mild cognitive impairment associated with Lewy bodies, a common but often-missed form of dementia. The findings could help clinicians catch the disease earlier, potentially opening doors for faster treatment and better patient outcomes before serious decline occurs.EN

Researchers found that cardiorespiratory fitness correlates with increased blood flow to the brain in older adults and heart disease patients—suggesting exercise may protect cognition through a vascular mechanism. The finding could reshape how cardiologists and neurologists approach dementia prevention, with implications for clinical guidelines and public health investment in cardiac rehabilitation programs.EN

Researchers have validated a method that integrates multiple types of brain imaging, blood biomarkers, and cardiovascular data into a single diagnostic tool—outperforming traditional single-marker approaches. The framework could streamline dementia screening and help identify at-risk patients earlier, with major implications for clinical trial design and insurance coverage strategies.EN

Researchers expected inflammation in the aging brain to worsen memory loss, but found the opposite: higher inflammatory markers correlated with better cognitive preservation. The counterintuitive result challenges how the medical and biotech industries approach cognitive aging treatments, suggesting current anti-inflammatory strategies may need rethinking.EN

Researchers have discovered that frontotemporal dementia-causing tau mutations activate fundamentally distinct disease mechanisms—one triggering cytoskeletal collapse, the other seed formation and aging-related aggregation. This mechanistic divergence could explain why tau diseases vary so wildly in severity and progression, and suggests precision treatments may need to target specific mutation types rather than tau broadly.EN

Researchers found that personality and behavior shifts in older adults—not just memory problems—reliably signal early Alzheimer's disease at the biological level. The discovery could let doctors and insurers identify at-risk patients sooner, opening a window for preventive treatments before cognitive decline becomes irreversible.EN

Researchers found that ADAM10, a protein involved in Alzheimer's disease progression, is significantly reduced in the brains and cerebrospinal fluid of patients with the disease. The discovery could enable earlier detection and help drug developers target this specific mechanism, potentially offering a biological marker for diagnosis before symptoms become severe.EN

Researchers have validated a promising Alzheimer's biomarker in serum—the standard sample type used by most clinical labs—matching its performance in plasma. The finding could accelerate adoption of p-tau217 blood testing across hospitals and clinics, potentially enabling earlier disease detection without requiring specialized sample handling.EN

Researchers have made it possible to combine brain imaging data from different hospitals and machines by standardizing how they measure neuroinflammation in Alzheimer's and related diseases. The breakthrough could accelerate drug development and clinical trials by pooling patient data across institutions—reducing costs and speeding time-to-market for new treatments.EN

A new study finds that corticobasal syndrome, a progressive neurological disorder, stems from six distinct underlying causes—most commonly tau buildup but also Alzheimer's disease and other pathologies. The discovery could reshape how doctors diagnose and treat the condition, potentially unlocking targeted therapies for a disease previously treated as one-size-fits-all.EN

Researchers found that how well people remember the first words in a recall test correlates with blood markers of Alzheimer's disease—before any cognitive decline appears. The discovery could enable cheaper, faster screening for at-risk individuals in primary care and clinical trials, potentially shifting disease detection from expensive imaging to routine office-based assessment.EN

A Swedish trial shows that Talking Mats—a low-tech communication aid using pictures and symbols—significantly increases how involved people with dementia feel when planning their home care. For municipalities and care providers struggling to meet both ethical standards and operational efficiency, the finding suggests a practical, scalable way to include vulnerable patients in decisions about their own lives.EN

People carrying a common Alzheimer's risk gene show tau protein buildup at much lower amyloid levels than others, according to analysis of 400+ patients. The finding explains why some patients progress faster and could reshape diagnostic criteria and treatment eligibility for early-stage disease.EN

The World Health Organization's ICD-11 now includes a dedicated diagnosis code for adult undernutrition, marking a major shift in how hospitals and insurers track and treat malnutrition cases. The change enables better clinical management, standardized data collection, and improved resource allocation for a condition affecting millions worldwide.EN

A major study of nearly 1 million heart attack cases finds that frail patients under 55 face mortality risks nearly seven times higher than their fit peers—a gap far larger than seen in older patients. The finding challenges assumptions about age and recovery, with major implications for how hospitals triage and manage younger cardiac patients.EN